Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells

BACKGROUND AND AIMS: The activating mutation BRAF(V600E) is a frequent genetic event in papillary thyroid carcinomas (PTC). Mutation BRAF(V600E) is associated with the loss of a sodium/iodine symporter (NIS), and subsequent radioiodide-refractory (RAI) metastatic disease. Use of BRAF V600E inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Honglai, Chen, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180498/
https://www.ncbi.nlm.nih.gov/pubmed/30337961
http://dx.doi.org/10.1186/s13044-018-0057-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180498/
https://www.ncbi.nlm.nih.gov/pubmed/30337961
http://dx.doi.org/10.1186/s13044-018-0057-6

Ejemplares similares